MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control

Messenger RNA (mRNA) technology is gaining attention for its potential in developing next-generation therapeutics. However, developing effective protein expression control technologies to regulate mRNA translation, particularly in a cell type- and tissue-specific manner, remains challenging. To achieve enhanced precision in translational regulation, we developed a microRNA (miRNA)-sensing hybrid mRNA switch, integrating an ON-type switch, which activates translation by detecting specific miRNAs expressed in target cells, into an OFF-type switch, which represses translation by sensing another miRNA in non-target cells. We first investigated effective module sequences after the poly(A)-tail for the ON-type mRNA switch to ensure appropriate translational activation in response to target cell-specific miRNAs. Moreover, the hybrid mRNA switch with a dual miRNA-sensing system reduced expression leakage in non-target cells and enhanced ON/OFF selectivity <i>in vitro</i> human cell cultures and <i>in vivo</i> mouse model. This ON-OFF hybrid mRNA switch technology allows for the selective expression of target proteins in designated cells and holds promise for the next generation of mRNA therapeutics.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2025-06-16
DOI
https://doi.org/10.1016/j.omtn.2025.102609
Citations
4
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control

Yoshihiko Fujita, Kaito Masaki, Hirohide Saito
4 citations
Molecular Therapy — Nucleic Acids
RNA Interference and Gene Delivery
3.22
article

MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control

Yoshihiko Fujita, Kaito Masaki, Hirohide Saito
article en
4 citations

Abstract

Messenger RNA (mRNA) technology is gaining attention for its potential in developing next-generation therapeutics. However, developing effective protein expression control technologies to regulate mRNA translation, particularly in a cell type- and tissue-specific manner, remains challenging. To achieve enhanced precision in translational regulation, we developed a microRNA (miRNA)-sensing hybrid mRNA switch, integrating an ON-type switch, which activates translation by detecting specific miRNAs expressed in target cells, into an OFF-type switch, which represses translation by sensing another miRNA in non-target cells. We first investigated effective module sequences after the poly(A)-tail for the ON-type mRNA switch to ensure appropriate translational activation in response to target cell-specific miRNAs. Moreover, the hybrid mRNA switch with a dual miRNA-sensing system reduced expression leakage in non-target cells and enhanced ON/OFF selectivity <i>in vitro</i> human cell cultures and <i>in vivo</i> mouse model. This ON-OFF hybrid mRNA switch technology allows for the selective expression of target proteins in designated cells and holds promise for the next generation of mRNA therapeutics.

Molecular Therapy — Nucleic AcidsVol. 36(3)
Kyoto University (JP), The University of Tokyo (JP)
Japan Agency for Medical Research and Development, Kyoto University, Japan Society for the Promotion of Science, Japan Science and Technology Agency, Core Research for Evolutional Science and Technology
Zero hunger
Openalex Percentile: Top 8%
RNA Interference and Gene Delivery
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control — Yoshihiko Fujita, Kaito Masaki, et al. · Molecular Therapy — Nucleic Acids (2025) | TGRS Research Map | TGRS